Identifying natural products for gastric cancer treatment through pharmacophore creation, 3D QSAR, virtual screening, and molecular dynamics studies

Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer

(2022) Xiao-dong Chu et al.   BMC CANCER

Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway

(2022) In-Hye Ham et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases

(2022) Asadollah Mohammadi et al.   MICROBIAL PATHOGENESIS

Accuracy evaluation of combining gastroscopy, multi-slice spiral CT, Her-2, and tumor markers in gastric cancer staging diagnosis

(2022) Songbo Zhao et al.   World Journal of Surgical Oncology

Calreticulin enhances gastric cancer metastasis by dimethylating H3K9 in the E-cadherin promoter region mediating by G9a

(2022) Lina Wang et al.   Oncogenesis

Berberine retarded the growth of gastric cancer xenograft tumors by targeting hepatocyte nuclear factor 4α

(2022) Ling-Li Li et al.   World Journal of Gastrointestinal Oncology

N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients

(2022) Shuyu Xu et al.   BMC CANCER

Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial

(2022) Jinming Shi et al.   BMC GASTROENTEROLOGY

Analysis of gastric microbiome reveals three distinctive microbial communities associated with the occurrence of gastric cancer

(2022) Dehua Liu et al.   BMC MICROBIOLOGY

A new approach against Helicobacter pylori using plants and its constituents: A review study

(2022) Sankaran Sathianarayanan et al.   MICROBIAL PATHOGENESIS

Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis—a cohort study of 123 patients from a non-endemic country

(2022) Haithem Zaafouri et al.   World Journal of Surgical Oncology

Molecular dynamics simulations, molecular docking, and kinetics study of kaempferol interaction on Jack bean urease: Comparison of extended solvation model

(2022) Leila Zolghadr et al.   Food Science & Nutrition

PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway

(2022) Yueda Chen et al.   Cell Death Discovery

Discovery and evaluation of cytisine N-isoflavones as novel EGFR/HER2 dual inhibitors

(2022) Yanqing Wang et al.   BIOORGANIC CHEMISTRY

A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression as a Downstream Effector of Cadherin 1

(2022) Qiang Yan et al.   Journal of Oncology

Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms

(2022) Valentina Pozzi et al.   Biomolecules

Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer

(2022) Giorgio Malpeli et al.   Journal of Personalized Medicine

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer

(2021) A‐Kao Zhu et al.   KAOHSIUNG JOURNAL OF MEDICAL SCIENCES

Cancer statistics for the year 2020: An overview

(2021) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Pharmacodynamic stance of Phytoconstituents as a gastric ulcer protective mechanism: An overview

(2021) Manish Pal Singh et al.   CURRENT MOLECULAR MEDICINE

Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition PIM-1 kinase activity

(2020) Sujin Kim et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways

(2020) Qiang Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer

(2020) Li-Yan Wang et al.   World Journal of Clinical Cases

Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma

(2020) Li Zhang et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

The NCI-N87 Cell Line as a Gastric Epithelial Model to Study Cellular Uptake, Trans-Epithelial Transport, and Gastric Anti-Inflammatory Properties of Anthocyanins

(2019) Allison Atnip et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition

(2019) Sarfaraz Alam et al.   Scientific Reports

Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells

(2019) Yuyi Li et al.   GENE

TEMPORARY REMOVAL: CDH17 alters MMP-2 expression via canonical NF-κB signalling in human gastric cancer

(2018) Xiao-jie Jiang et al.   GENE

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells

(2018) Hung-Sheng Shang et al.   ENVIRONMENTAL TOXICOLOGY

Comparative Proteomic Profiling of Tumor-Associated Proteins in Human Gastric Cancer Cells Treated with Pectolinarigenin

(2018) Ho Jeong Lee et al.   Nutrients

Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases

(2017) Taiwo Ayeleso et al.   MOLECULES

Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells

(2017) Fatemeh Alibeiki et al.   Scientific Reports

Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation

(2017) Maryam Abbasi et al.   DARU-Journal of Pharmaceutical Sciences

Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease

(2016) Valentina Cappello et al.   Scientific Reports

Anticancer potential of medicinal plants and their phytochemicals: a review

(2015) Shruti Shukla et al.   Brazilian Journal of Botany

Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study

(2014) Timothy Iveson et al.   LANCET ONCOLOGY

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

(2013) Florian Lordick et al.   LANCET ONCOLOGY

Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

(2012) H.-J. Nam et al.   MOLECULAR CANCER THERAPEUTICS

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

(2011) Atsushi Ohtsu et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastric Cancer-Specific Protein Profile Identified Using Endoscopic Biopsy Samples via MALDI Mass Spectrometry

(2010) Hark Kyun Kim et al.   JOURNAL OF PROTEOME RESEARCH

Identification of c-Src as a Potential Therapeutic Target for Gastric Cancer and of MET Activation as a Cause of Resistance to c-Src Inhibition

(2010) W. Okamoto et al.   MOLECULAR CANCER THERAPEUTICS

Comments on the Definition of theQ2Parameter for QSAR Validation

(2009) Viviana Consonni et al.   Journal of Chemical Information and Modeling